Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Cetrimide; Chlorhexidine acetate
Baxter Healthcare Ltd
D08AC52
Cetrimide; Chlorhexidine acetate
1.5mg/1ml ; 150microgram/1ml
Cutaneous irrigation solution
Cutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF: 13110200; GTIN: 5413760020310
OBJECT 1 CHLORHEXIDINE ACETATE 0.015% W/V AND CETRIMIDE 0.15% W/V, IRRIGATION Summary of Product Characteristics Updated 29-Sep-2016 | Baxter Healthcare Ltd 1. Name of the medicinal product Chlorhexidine Acetate 0.015% w/v and Cetrimide 0.15% w/v, Irrigation Solution 2. Qualitative and quantitative composition Chlorhexidine Acetate BP 0.15g/1000ml Cetrimide Ph.Eur 1.5g/1000ml 3. Pharmaceutical form Chlorhexidine Acetate 0.015% w/v and Cetrimide 0.15% w/v, Irrigation Solution is a clear, yellow, sterile, aqueous solution for general topical use. 4. Clinical particulars 4.1 Therapeutic indications Chlorhexidine Acetate 0.015% w/v and Cetrimide 0.15% w/v, Irrigation Solution is for general topical use, combining antibacterial activity against a wide range of vegetative gram-positive and gram-negative bacteria with useful cleansing properties. The solution is recommended for the cleansing and disinfection of wounds and the antiseptic treatment of burns. Chlorhexidine Acetate 0.015% w/v and Cetrimide 0.15% w/v, Irrigation Solution is recommended for swabbing in obstetrics, gynaecology and urology. 4.2 Posology and method of administration DOSAGE Dosage and duration of administration are to be individualized and depend upon the indication for use, the patient's age, weight, clinical condition, and concomitant treatment, and on patient's clinical response to treatment (See Section 4.4 Chemical Burns in Neonates and Preoperative Skin Preparation). ADMINISTRATION Chlorhexidine Acetate 0.015% w/v and Cetrimide 0.15% w/v, Irrigation Solution is for general topical use. This solution is used undiluted for topical application only. Not for intravenous or oral route of administration. 4.3 Contraindications This solution should not be used in the eye, intravenously, orally, in the auditory canal (especially in perforated eardrums), or near meninges brain or spinal cord (See Section 4.4 Special Warnings and Precautions for Use). In patients with a known hypersensitivity to the product or any of its components, especially in thos Read the complete document